Developer docs
API playgroundTry for free, no card

Search company profiles

CluePoints

Full company profile

uuid0005e52

Namestring
CluePoints
Legal namestring
CluePoints SA
Websiteurl
cluepoints.com
Company typeenum
Private
Founded yearint
2012
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLouvain-la-neuve, Belgium
HQ citystring
Louvain-la-neuve
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial monitoring, risk-based quality management, central statistical monitoring, clinical data oversight, medical coding automation
Industry3 codes
PRIMARYHLACAOAI
Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code3 codes
  • Computer Systems Design and Related Services54151
  • Custom Computer Programming Services541511
  • Other Computer Related Services541519
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Clinical Trial Risk-Based Quality Management Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Enterprise software-as-a-service platform for RBQM and data quality oversight delivered via cloud-based deployment. SaaS V1 released in 2015.

cluepoints.com
2Professional Services
TypeProfessional Services
Description

Implementation support, configuration, and consulting services for RBQM deployment, site inspection readiness, and central monitoring.

cluepoints.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise SaaS platform with multiple product modules
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing. Multiple modules available: RBQM, SPOT, Intelligent Medical Coding, Medical & Safety Review, Intelligent Query Detection. Sales team available for personalized demos and pricing discussions.

cluepoints.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

CluePoints provides a cloud-based Risk-Based Quality Management (RBQM) software platform for clinical trial oversight. The platform combines advanced statistics, machine learning, deep learning, and natural language processing to detect data anomalies, fraud, and quality risks across clinical trial sites, patients, and countries. The offering is delivered as a SaaS platform with modular products including SPOT (site monitoring), Intelligent Medical Coding, Medical & Safety Review (MSR), and Intelligent Query Detection (IQD), targeted at pharmaceutical sponsors, CROs, medical device companies, and academic institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 20-30% of medical coding terms previously required manual processes; CluePoints aims to cut coding effort in half
+4 more records
Product overview1 text field

CluePoints offers a unified RBQM platform architecture built on its proprietary SMART™ Engine (patented statistical technology). The core Risk-Based Quality Management platform provides centralized data oversight and anomaly detection, supplemented by specialized modules including SPOT (site monitoring), Intelligent Medical Coding (deep learning-powered coding automation), Medical & Safety Review (MSR for centralized data review), and Intelligent Query Detection (IQD using LLMs for automated discrepancy detection). All modules share the underlying statistical monitoring engine and integrate to deliver end-to-end risk-based quality oversight from trial design through regulatory submission.

Product and service5 records
1Risk-Based Quality Management (RBQM)
CategoryRisk-Based Quality Management Software
Description

AI-powered RBQM platform that identifies real-time data anomalies in clinical trials through cutting-edge statistics and machine learning, enabling proactive risk management across all trial phases in compliance with FDA and ICH guidelines. Targeted at pharmaceutical sponsors, CROs, medical device companies, and academic institutions.

2Site Profile & Oversight Tool (SPOT)
CategoryClinical Trial Site Monitoring Software
Description

Adaptive site monitoring tool enabling clinical research teams to pinpoint anomalies and translate insights into actionable strategies, improving site visit planning, performance evaluation, and risk assessment by consolidating diverse data sources into a single view. Targeted at clinical operations and monitoring teams within pharma sponsors and CROs.

3Intelligent Medical Coding
CategoryMedical Coding Automation Software
Description

Deep learning-powered automated medical coding solution providing suggestions at up to 99% accuracy for adverse events and concomitant medications using WHODrug and MedDRA dictionaries. Reduces manual coding effort by up to 50% and ensures consistency across clinical trial data. Targeted at clinical data management teams.

4Medical & Safety Review (MSR)
CategoryClinical Data Review Software
Description

Centralized clinical data review platform providing customizable dashboards, automated record change monitoring, and frequent data refreshes with consolidated data synchronization. Enables efficient query management throughout clinical trials and integrates with EDC systems via API. Targeted at clinical data and safety review teams.

5Intelligent Query Detection (IQD)
CategoryClinical Data Query Management Software
Description

AI-powered data discrepancy detection tool using high-precision large language models (LLMs) to automate query identification, provide suggested query text for consistent communication, and integrate with EDC systems. Reduces manual workload and improves query accuracy through continuous learning. Targeted at clinical data management teams.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Ongoing Cooperative Research and Development Agreement (CRADA) with FDA for data-driven site anomaly identification using SMART technology. First initiated in 2016.

2TransCelerate Biopharma
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Active collaboration member contributing to improving R&D, enhancing study quality and compliance, setting new industry standards, and advancing data analysis and reporting in clinical research.

cluepoints.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration member focused on industry quality standards and best practices in clinical research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Member contributing to ACRO's mission of advancing clinical research through collaboration and industry standards.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration member working toward shared goals in clinical data transparency and standards development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on AI, machine learning, and natural language processing initiatives to improve data quality and integrity in clinical trials. Pfizer COVID-19 vaccine trial supported.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for AI-powered data quality and integrity improvements using CluePoints' analytical approaches.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Y-Prime provides eClinical and IRT platforms with clinical data management and oversight tooling. It is a smaller competitor touching similar pharma RBQM/oversight workflows.

TypeBroad incumbent
Description

IQVIA combines CRO scale with proprietary clinical technology (e.g., E360, CTMS, analytics). Its embedded RBQM and data-management tools compete with CluePoints within the same pharma procurement cycles.

TypeDirect peer
Description

Medidata provides the Rave clinical trial platform spanning EDC, CTMS, eCOA, and risk-based monitoring. Its Rave RBM offering competes head-to-head with CluePoints' RBQM core product for sponsor and CRO analytics budgets.

TypeDirect peer
Description

Saama provides AI-driven clinical development analytics and trial data platforms, including risk-based monitoring and centralized monitoring. It competes with CluePoints on AI-led RBQM analytics for pharma and CRO clients.

TypeDirect peer
Description

Signant Health (formerly Bracket) provides eCOA, RBQM, and clinical technology solutions to pharma and CROs. CluePoints' Chief Professional Services Officer came from Signant, and the two compete directly in RBQM, site monitoring, and clinical data oversight.

TypeBroad incumbent
Description

Veeva is a dominant provider of cloud-based life sciences software, including CTMS, EDC, and clinical data management. CluePoints' former CSO came from Veeva, and Veeva's clinical platform overlaps directly with CluePoints' RBQM and MSR modules, making it the most strategically relevant incumbent comparator.

TypeEmerging player
Description

Precision for Medicine (PFM) provides clinical and data services plus technology for biomarker-driven trials. While broader than pure RBQM, it overlaps with CluePoints' centralized statistical monitoring for specialty/biotech trials.

TypeDirect peer
Description

Clario (formed via the merger of Bioclinica and ERT) delivers eCOA, cardiac safety, imaging, and clinical endpoint technology. Its endpoint and data-quality offerings compete with CluePoints' MSR, SPOT, and central monitoring capabilities.

TypeOthers
Description

Bioforum is a clinical data management CRO that, like CluePoints, originated from the IDDI statistical lineage. It serves similar sponsors and CROs on clinical data/biometrics, though as a services competitor rather than a platform peer.

10Oracle Health Sciences Clinical One
TypeBroad incumbent
Description

Oracle's Clinical One platform unifies EDC, RTSM, and clinical data management. As a broader enterprise platform, it overlaps with CluePoints' data-quality, query, and oversight capabilities within a wider portfolio.

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CluePoints

Clinical Trial Risk-Based Quality Management Softwarecluepoints.com

CluePoints firmographics

Firmographics
Name
CluePoints
Legal name
CluePoints SA
Website
https://cluepoints.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

CluePoints industry classification

Industry
Product category
Clinical Trial Risk-Based Quality Management Software
NAICS
Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511), Other Computer Related Services (541519)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLACAOAI
Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial monitoring
  • Risk-based quality management
  • Central statistical monitoring
  • Clinical data oversight
  • Medical coding automation

Where CluePoints is headquartered

Location

Headquarters

HQ city
Louvain-la-neuve
HQ country
Belgium
HQ region
Europe

Offices4 records

Markets served

CluePoints business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription: Enterprise software-as-a-service platform for RBQM and data quality oversight delivered via cloud-based deployment. SaaS V1 released in 2015.
  2. Professional Services: Implementation support, configuration, and consulting services for RBQM deployment, site inspection readiness, and central monitoring.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS platform with multiple product modules

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

CluePoints product offering

Product offering

Core offering

CluePoints provides a cloud-based Risk-Based Quality Management (RBQM) software platform for clinical trial oversight. The platform combines advanced statistics, machine learning, deep learning, and natural language processing to detect data anomalies, fraud, and quality risks across clinical trial sites, patients, and countries. The offering is delivered as a SaaS platform with modular products including SPOT (site monitoring), Intelligent Medical Coding, Medical & Safety Review (MSR), and Intelligent Query Detection (IQD), targeted at pharmaceutical sponsors, CROs, medical device companies, and academic institutions.

Product overview

CluePoints offers a unified RBQM platform architecture built on its proprietary SMART™ Engine (patented statistical technology). The core Risk-Based Quality Management platform provides centralized data oversight and anomaly detection, supplemented by specialized modules including SPOT (site monitoring), Intelligent Medical Coding (deep learning-powered coding automation), Medical & Safety Review (MSR for centralized data review), and Intelligent Query Detection (IQD using LLMs for automated discrepancy detection). All modules share the underlying statistical monitoring engine and integrate to deliver end-to-end risk-based quality oversight from trial design through regulatory submission.

Differentiator

Problem solved

Functional benefit

Products and services

  • Risk-Based Quality Management (RBQM) AI-powered RBQM platform that identifies real-time data anomalies in clinical trials through cutting-edge statistics and machine learning, enabling proactive risk management across all trial phases in compliance with FDA and ICH guidelines. Targeted at pharmaceutical sponsors, CROs, medical device companies, and academic institutions.
  • Site Profile & Oversight Tool (SPOT) Adaptive site monitoring tool enabling clinical research teams to pinpoint anomalies and translate insights into actionable strategies, improving site visit planning, performance evaluation, and risk assessment by consolidating diverse data sources into a single view. Targeted at clinical operations and monitoring teams within pharma sponsors and CROs.
  • Intelligent Medical Coding Deep learning-powered automated medical coding solution providing suggestions at up to 99% accuracy for adverse events and concomitant medications using WHODrug and MedDRA dictionaries. Reduces manual coding effort by up to 50% and ensures consistency across clinical trial data. Targeted at clinical data management teams.
  • Medical & Safety Review (MSR) Centralized clinical data review platform providing customizable dashboards, automated record change monitoring, and frequent data refreshes with consolidated data synchronization. Enables efficient query management throughout clinical trials and integrates with EDC systems via API. Targeted at clinical data and safety review teams.
  • Intelligent Query Detection (IQD) AI-powered data discrepancy detection tool using high-precision large language models (LLMs) to automate query identification, provide suggested query text for consistent communication, and integrate with EDC systems. Reduces manual workload and improves query accuracy through continuous learning. Targeted at clinical data management teams.

Quantifiable outcome

  • 20-30% of medical coding terms previously required manual processes; CluePoints aims to cut coding effort in half
  • +4 more outcomes

Companies that use CluePoints

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

CluePoints technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature9 records

CluePoints partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • FDA (Food and Drug Administration)coreStrategic or Co-development Partner · 1 January 2016Ongoing Cooperative Research and Development Agreement (CRADA) with FDA for data-driven site anomaly identification using SMART technology. First initiated in 2016.
  • TransCelerate BiopharmacoreStrategic or Co-development PartnerActive collaboration member contributing to improving R&D, enhancing study quality and compliance, setting new industry standards, and advancing data analysis and reporting in clinical research.
  • Avoca Quality ConsortiumcoreStrategic or Co-development PartnerCollaboration member focused on industry quality standards and best practices in clinical research.
  • Association of Clinical Research Organizations (ACRO)coreStrategic or Co-development PartnerMember contributing to ACRO's mission of advancing clinical research through collaboration and industry standards.
  • PHUSEcoreStrategic or Co-development PartnerCollaboration member working toward shared goals in clinical data transparency and standards development.
  • PfizercoreStrategic or Co-development PartnerCollaboration on AI, machine learning, and natural language processing initiatives to improve data quality and integrity in clinical trials. Pfizer COVID-19 vaccine trial supported.
  • GSKcoreStrategic or Co-development PartnerPartnership for AI-powered data quality and integrity improvements using CluePoints' analytical approaches.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

CluePoints competitors and assessment

Company assessment

Emerging players

  • Y-Prime: Y-Prime provides eClinical and IRT platforms with clinical data management and oversight tooling. It is a smaller competitor touching similar pharma RBQM/oversight workflows.
  • Precision for Medicine: Precision for Medicine (PFM) provides clinical and data services plus technology for biomarker-driven trials. While broader than pure RBQM, it overlaps with CluePoints' centralized statistical monitoring for specialty/biotech trials.

Broad incumbents

  • IQVIA Technologies: IQVIA combines CRO scale with proprietary clinical technology (e.g., E360, CTMS, analytics). Its embedded RBQM and data-management tools compete with CluePoints within the same pharma procurement cycles.
  • Veeva Systems: Veeva is a dominant provider of cloud-based life sciences software, including CTMS, EDC, and clinical data management. CluePoints' former CSO came from Veeva, and Veeva's clinical platform overlaps directly with CluePoints' RBQM and MSR modules, making it the most strategically relevant incumbent comparator.
  • Oracle Health Sciences Clinical One: Oracle's Clinical One platform unifies EDC, RTSM, and clinical data management. As a broader enterprise platform, it overlaps with CluePoints' data-quality, query, and oversight capabilities within a wider portfolio.

Direct peers

  • Medidata Solutions (Dassault Systèmes): Medidata provides the Rave clinical trial platform spanning EDC, CTMS, eCOA, and risk-based monitoring. Its Rave RBM offering competes head-to-head with CluePoints' RBQM core product for sponsor and CRO analytics budgets.
  • Saama Technologies: Saama provides AI-driven clinical development analytics and trial data platforms, including risk-based monitoring and centralized monitoring. It competes with CluePoints on AI-led RBQM analytics for pharma and CRO clients.
  • Signant Health: Signant Health (formerly Bracket) provides eCOA, RBQM, and clinical technology solutions to pharma and CROs. CluePoints' Chief Professional Services Officer came from Signant, and the two compete directly in RBQM, site monitoring, and clinical data oversight.
  • Clario: Clario (formed via the merger of Bioclinica and ERT) delivers eCOA, cardiac safety, imaging, and clinical endpoint technology. Its endpoint and data-quality offerings compete with CluePoints' MSR, SPOT, and central monitoring capabilities.

Others

  • Bioforum (Bioforum the Data Master): Bioforum is a clinical data management CRO that, like CluePoints, originated from the IDDI statistical lineage. It serves similar sponsors and CROs on clinical data/biometrics, though as a services competitor rather than a platform peer.

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CluePoints social profiles

Digital presence

CluePoints compliance and trust

Trust signal

Compliance3 records

CluePoints financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CluePoints leadership team

Management profile

Number of profiles

Profiles10 records

CluePoints funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CluePoints M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CluePoints

What does CluePoints do?

CluePoints provides a cloud-based Risk-Based Quality Management (RBQM) software platform for clinical trial oversight. The platform combines advanced statistics, machine learning, deep learning, and natural language processing to detect data anomalies, fraud, and quality risks across clinical trial sites, patients, and countries. The offering is delivered as a SaaS platform with modular products including SPOT (site monitoring), Intelligent Medical Coding, Medical & Safety Review (MSR), and Intelligent Query Detection (IQD), targeted at pharmaceutical sponsors, CROs, medical device companies, and academic institutions.

Is CluePoints a public or private company?

CluePoints is a private company. It is classified as venture growth investor backed and is currently operating.

When was CluePoints founded?

CluePoints was founded in 2012. It employs 251 to 500 people.

Where is CluePoints based?

CluePoints is headquartered in Louvain-la-neuve, Belgium, in the Europe region.

How does CluePoints make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services.

Who are CluePoints's main competitors?

Emerging players on record are Y-Prime and Precision for Medicine. Broad incumbents are IQVIA Technologies, Veeva Systems and Oracle Health Sciences Clinical One. Direct peers are Medidata Solutions (Dassault Systèmes), Saama Technologies, Signant Health and Clario. Bioforum (Bioforum the Data Master) is listed as an others.

Does CluePoints have an API?

No public API is recorded for CluePoints.

What industry is CluePoints in?

CluePoints's product category is Clinical Trial Risk-Based Quality Management Software. Its primary akta.pro industry code is HLACAOAI, Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management, with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCluePoints Announced as Fierce Life Sciences Innovation Awards FinalistCluePoints was named a finalist in the Data Analytics/Business Intelligence category at the 2026 Fierce Life Sciences Innovation Awards. The company's RBQM software includes three new capabilities—Intelligent Query Detection, Medical and Safety Review, and Intelligent Medical Coding—and has detected over 250,000 potential issues. Winners will be announced at the Fierce Vanguard Awards Gala on November 19, 2026.PR NewswireCluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical CompanyCluePoints announced general availability of three AI-led clinical data review capabilities—Intelligent Query Detection, Medical & Safety Review, and Intelligent Medical Coding—co-innovated with a top-10 pharmaceutical company. The capabilities are live in most ongoing studies, including mega-studies, and will be demonstrated at SCDM 2026.Third NewsCluePoints Welcomes Martin Magazzolo as New Chief Commercial OfficerCluePoints, a provider of AI-powered statistical software for the life sciences industry, has appointed Martin Magazzolo as its new Chief Commercial Officer. Magazzolo joins from Honeywell, where he served as CCO for the Life Sciences business unit, bringing over 30 years of executive leadership experience across life sciences, healthcare technology, and software sectors. Pat Hughes, the company's co-founder who led commercial efforts since inception, is transitioning to a Strategic Advisor role as part of this leadership change.SalesTech StarCluePoints Appoints Martin Magazzolo as Chief Commercial OfficerCluePoints appointed Martin Magazzolo as Chief Commercial Officer, leading its global commercial organization. He joins from Honeywell's Life Sciences business unit, succeeding Pat Hughes, who becomes a strategic advisor. He will focus on expanding RBQM and data quality oversight solutions.PR NewswireCluePoints Appoints Martin Magazzolo as Chief Commercial OfficerCluePoints appointed Martin Magazzolo as Chief Commercial Officer, leading its global commercial organization. He joins from Honeywell, succeeding Pat Hughes, who becomes a strategic advisor. The appointment aims to expand CluePoints' RBQM and data quality oversight solutions in the life sciences industry.PR NewswireCluePoints and Tufts CSDD Publish Peer-Reviewed Evidence Quantifying the Financial Value of RBQMCluePoints and Tufts Center for the Study of Drug Development co-authored peer-reviewed research published in Therapeutic Innovation & Regulatory Science, providing the industry's first quantitative business case for risk-based quality management (RBQM) in clinical development. The study, analyzing 18 oncology trials on the CluePoints platform, found that RBQM-enabled trials achieved 8-19% reductions in clinical phase durations and generated 6x-23x ROI multiples at the trial level, with financial returns ranging from $3.2M in Phase 1 to $18.9M in Phase 3. The research addresses a longstanding industry gap by translating RBQM impact into measurable metrics around time savings, costs, and portfolio value, offering evidence-based justification for scaling RBQM adoption across drug development programs.PR NewswireCluePoints Appoints New Chief People Officer to Support Next Phase of Global GrowthCluePoints, a provider of statistical and AI-driven software solutions for clinical trials, has appointed Sinead Godkin as its new Chief People Officer. Godkin previously served as CPO at DigiCert and brings experience from Veritas Technologies and Symantec, and will lead CluePoints' people strategy as the company enters its next stage of global expansion. The company reported recruiting more than 100 new team members in 2025 as part of its rapid growth trajectory.PR NewswireCluePoints Scoops Prestigious 2025 Scrip AwardCluePoints, a provider of statistical and AI-driven software solutions for clinical trials, won the 'Best Contract Research Organization – Specialist Providers' category at the 2025 Scrip Awards ceremony held on December 11, 2025 in London. The award recognized CluePoints' technology tools that help reshape clinical trial operations, including its Time Similarity Test feature that identifies data anomalies in electronic patient-reported outcomes to improve data quality and regulatory readiness. The company recently expanded its multi-product SaaS platform with new capabilities such as its Medical & Safety Review software designed to streamline clinical data review and medical oversight.PharmiWeb.comCluePoints Data and Knowledge Manager Appointed to ACT Editorial Advisory BoardCluePoints announced that Sylviane de Viron, its Data and Knowledge Manager, has been appointed to the Applied Clinical Trials (ACT) editorial advisory board. Her appointment aims to advance knowledge of risk-based quality management (RBQM) throughout the clinical trial industry. Sylviane de Viron, who holds a PhD in Public Health from Maastricht University and has published articles on KRI overload and fraud detection in clinical trials, will contribute to shaping topics that drive the evolution of clinical trials.